Week 310 Review - Really bad week and no sign of hope

Week after week of rubbish performance across the board. Nearly everything was down this week, and with OPTI:Optibiotix losing 3p the damage to the portfolio was £6,398, widening the deficit between cost and value to £33,092 and reducing overall value to £111,697. It's just a massive relief that despite things being really bad, the value has stayed above £100k. Dropping below that would be morale crushing.

JLP:Jubilee Metals dropped 30% of my purchase price, probably as a result of the troubles in South Africa. They are still 297% up so I'll not panic just yet.

OPTI:Optibiotix fell 5% which cost me £4,800 of this week's losses. We desperately need SweetBiotix news to get us out of this trading range.

Share of the Week was TLOU:Tlou Energy, which only climbed 3% but was by far the biggest riser this week. A sorry state of affairs.

The recent slight recovery appears to have been a blip

Here's the ISA and shares portfolio after week 50 of year 6.

			Weekly Change
Cash	£35.33		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£54,277.02	(-20.4%)	-£3,414.10
Potential profits	£6,424.08		-£650.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		+£0
Yr 6 projected avg monthly profit	£316.54	(8.7%)	-£6.46
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£352.11	(9.6%)	-£1.14
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Big drop in potential profits thanks to JLP:Jubilee Metals, which rather troublingly is the only share even remotely close to being in profit in the portfolio. Only 2 more weeks of year 6 left and it's looking like it will be up there close to the long term performance, which isn't too bad given it's been a Covid year.

Closer to the orange line than the red which is bad.

I still can't believe that moment in the black 6 months ago was so brief

The SIPP looks like this after week 294 overall and week 34 of year 6.

			Weekly Change
Cash	£492.37		+£0
Portfolio cost	£73,458.48		+£0
Portfolio sell value (bid price - commission)	£55,288.24	(-24.7%)	-£2,934.44
Potential profits	£685.52		-£127.50
Yr 6 Dividends	£888.61		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£0
Yr 6 projected avg monthly profit	£1,087.05	(29.8%)	-£32.94
Total Dividends	£2,955.69		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£0
Average monthly cash profit	£374.89	(10.3%)	-£1.28
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+0%

After selling all my profitable magic formula shares, the only one left in profit is CAML:Central Asia Metals, and that dropped this week so potential profits are down £127. The new magic formula shares haven't got off to a very good start, but aren't down too much, and I do have a year to hold them

I've got another £2,000 arriving in my account next week from my work pension, so will be buying two more magic formula shares with that.

Given the costs has risen so much, the flat line is deceptive

That's a much more realistic, and somewhat devastating chart.

The trading account looks like this after week 260 overall and week 52 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,345.49	(-43.3%)	-£49.87
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£55.31	(28.0%)	-£1.08
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.63	(8.4%)	-£0.07
(Sold stocks profit + Dividends - Fees / Months)

Another bad week losing £49 value and going 43% down with no sign of being able to sell anything for quite a while. The good news is that we reached the end of year 5 with a fantastic 28% profit of £55 a month. I'm really pleased with that, and it helps make up for the rest of the gloom around the portfolio. Let's see if year 6 can get anywhere near that. It's not looking too promising so far.

Almost down to the injection line, which we haven't crossed for a while.

Well on the bright side, it makes a nice mountain picture!

Looking forward to getting my £2,000 pension transfer next week. I will be resisting the temptation to buy more OPTI:Optibiotix or DDDD:4D Pharma shares while they are cheap, and SBTX:SkinBioTherapeutics is still too expensive to get back into, so I'll be buying more magic formula shares.

Week 309 Review - Flat again with no sign of uplift

A really flat and dull week. The deficit between cost and value widened by just £349 to £26,693 and total portfolio value dropped to £118,096.

The only big loser was TLOU:Tlou Energy dropping 5%, presumably on lack of news.

Share of the Week was JLP:Jubilee Metals rising 7% to go up by £327% altogether.

Stuck in a rut for months.

Here's the ISA and shares portfolio after week 49 of year 6.

			Weekly Change
Cash	£35.33		-£3.75
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£57,691.12	(-15.4%)	-£118.25
Potential profits	£7,074.08		-£150.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		+£0
Yr 6 projected avg monthly profit	£323.00	(8.8%)	-£7.06
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£353.25	(9.7%)	-£1.20
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

JLP:Jubilee Metals potential profits rose by £150 which more than halved the losses elsewhere to £118. Monthly fees were collected from the cash.

Flat

Less flat

The SIPP looks like this after week 293 overall and week 33 of year 6.

			Weekly Change
Cash	£492.37		-£2.67
Portfolio cost	£73,458.48		+£0
Portfolio sell value (bid price - commission)	£58,222.68	(-20.7%)	-£222.55
Potential profits	£813.02		-£37.50
Yr 6 Dividends	£888.61		+£14.10
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£0
Yr 6 projected avg monthly profit	£1,119.99	(30.7%)	-£35.36
Total Dividends	£2,955.69		+£14.10
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£0
Average monthly cash profit	£376.17	(10.3%)	-£1.33
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+0%

A £14 dividend was receive from FXPO:Ferrexpo which almost paid for the monthly SIPP fee but not quite. Potential profits slipped as CAML:Central Asia Metals fell slightly, but thankfully long term performance is still above target.

Firmly into a downwards trend.

The trading account looks like this after week 259 overall and week 51 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,395.36	(-41.2%)	-£9.05
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£56.39	(28.5%)	-£1.13
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.70	(8.4%)	-£0.07
(Sold stocks profit + Dividends - Fees / Months)

Hardly anything moved.

I'm late writing up again. My heart's just not in it at the moment. I'm suspecting it's going to be flat until September now.

Week 308 Review - Roller coaster week ends slightly up

By the end of trading on Monday I was £6,500 up and it was looking like a great week, but that vanished to a £2,500 loss as the week wore on, only to recover at the last minute to a £1,008 rise. That reduced the deficit between cost and value to £26,344 and increased total value to £118,452.

JLP:Jubilee Metals was the only big loser, giving up the 18% gain from last week, but they are still 320% up

OPTI:Optibiotix climbed by 1p which is only 2% but was almost enough to win Share of the Week.

The prize goes to TRX:Tissue Regenix which climbed 3%, a rise so small it wouldn't normally get a mention, but it was my best performer this week. They are still 60% down, but I haven't given up hope for them and am still tempted to get a few more at these prices.

Flat

A tiny tick up but well below the trend line

Here's the ISA and shares portfolio after week 48 of year 6.

			Weekly Change
Cash	£39.08		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£57,809.37	(-15.2%)	+£322.99
Potential profits	£6,924.08		-£400.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		+£0
Yr 6 projected avg monthly profit	£330.06	(9.0%)	-£7.03
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£354.45	(9.7%)	-£1.15
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

Only slightly up by £322 thanks to the £400 drop in JLP:Jubilee Metals in a pretty uneventful week.

Still below the trend line, but not by very much.

The SIPP looks like this after week 292 overall and week 32 of year 6.

			Weekly Change
Cash	£495.04		+£0
Portfolio cost	£73,458.48		+£0
Portfolio sell value (bid price - commission)	£58,445.23	(-20.4%)	+£682.69
Potential profits	£850.52		-£30.00
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£0
Yr 6 projected avg monthly profit	£1,155.35	(31.7%)	-£37.27
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£0
Average monthly cash profit	£377.50	(10.4%)	-£1.30
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+0%

Hardly anything happened here either. CAML:Central Asia Metals is the only share in profit and it dropped by just £30, and the 1p climb in OPTI:Optibiotix cancelled out all the small losses and gave an improvement of £682.

A lot further below the trend line, and it's now pointing downwards which is exceptionally bad.

The trading account looks like this after week 258 overall and week 50 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,404.41	(-40.8%)	+£2.70
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£57.52	(29.1%)	-£1.17
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.76	(8.5%)	-£0.07
(Sold stocks profit + Dividends - Fees / Months)

That pretty much sums up how little happened this week. In increase in value of £2. Only 2 weeks of year 5 left to go, and it's looking like the best ever performance with an average of over £55 a month profit. It would be nice to think I can sell something soon but it doesn't look likely, and transferring across the £2,500 from selling the OPTI:Optibiotix in my share account when it passes 84p is looking like a long, long way off yet.

A pretty rubbish 5 months.

That's it - late to write up again and I want something to eat, so no time to speculate on what may or may not happen next week. Suffice to say it's been a long, long time since we had a really good week.

Week 307 Review - Quiet week with some small recovery

Not an awful lot happened this week, but a slight recovery in some miners and a 2p increase in OPTI:Optibiotix led to a reduction in the deficit between cost and value of £3,270 to £27,352 and an increase in portfolio value to £117,443.

Only big loser was CMCL:Caledonia Mining which has been an utter disaster of an investment. Given most miners have increased, these have dropped 27% since I bought them and this week fell 7%.

FXPO:Ferrexpo did the opposite and recovered by 7%. They are only 1% down now, so fingers crossed will go back into profit next week.

Share of the Week was JLP:Jubilee Metals which climbed 18% of my original purchase price after a drop last week. They are 338% up and with the prospect of imminent news on copper production have a lot further to go yet.

I think that takes us slightly closer to the red line than the orange, but only just.

Well below the trend line which is getting flatter by the week.

Here's the ISA and shares portfolio after week 47 of year 6.

			Weekly Change
Cash	£39.08		+£0
Portfolio cost	£68,170.47		+£0
Portfolio sell value (bid price-commission)	£57,486.38	(-15.7%)	+£1,898.12
Potential profits	£7,324.08		+£400.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		+£0
Yr 6 projected avg monthly profit	£337.09	(9.2%)	-£7.32
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		+£0
Average monthly cash profit	£355.60	(9.7%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		+0%

A good week with potential profits for JLP:Jubilee Metals climbing by £400 and losses reducing by an additional £1,498.

Nice steep rise in this account. Might actually get to the trend line soon.

The SIPP looks like this after week 291 overall and week 31 of year 6.

			Weekly Change
Cash	£495.04		+£287.50
Portfolio cost	£73,458.48		+£0
Portfolio sell value (bid price - commission)	£57,762.54	(-21.4%)	+£1,415.73
Potential profits	£880.52		+£135.00
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£0
Yr 6 projected avg monthly profit	£1,192.62	(32.7%)	-£39.75
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£0
Average monthly cash profit	£378.80	(10.4%)	-£1.30
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+0%

Potential profits are up by £135 and that's all CAML:Central Asia Metals as everything else is making a loss after I sold all my magic formula shares. Cash went up by £287 due to a pension tax refund from recent contributions.

This account is normally the good one, but it's closer to the orange line than the ISA

The trend line is almost flat and we're still a long way below it.

The trading account looks like this after week 257 overall and week 49 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,401.71	(-41.0%)	-£43.14
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£58.69	(29.7%)	-£1.23
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.83	(8.5%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Everything dropped in value this week so things are looking pretty bad. Only 3 weeks until the end of Year 5 which will be my best ever year for this account.

Almost at the injection line. This needs a rocket up it.

Absolutely desperate.

I'm hoping the 2p rise in OPTI:Optibiotix is a precursor to it being given a chance to go on a run. Normally it gets stifled mercilessly, but it's about time we were given something to smile about.

Week 306 Review - Nearly everything drops and Motif Bio written off

An absolutely rubbish week with big losses all over the place, especially the miners. Thankfully OPTI:Optibiotix stayed flat else things would have been even worse. However, thanks to writing off MTFB:Motif Bio as a loss, the deficit between cost and value actually narrowed by £583, but overall portfolio value dropped by about £2,000 to £113,885.

CAML:Central Asia Metals was the biggest faller, and after a 9% drop last week it fell another 15% this week. It looks like there is a drop across the mining sector, but none of my others dropped this much. Metal prices have dropped, but surely this is a blip, as there are shortages of supply across the board.

FXPO:Ferrexpo dropped 10% confirming the timing of my re-entry was utterly dreadful.

JLP:Jubilee Metals fell 7%, but we should get this back as soon as news of copper production breaks, and 7% is a remarkably small change compared to what I usually get.

TLOU:Tlou Energy also dropped 7% but I have no idea why.

CEY:Centamin was another recent purchase and dropped 6% this week to go 9% down already.

POLY:Polymetal also dropped by a large sum, falling 5% as the gold price is falling.

There was only one share that gained in price this week, so RDT:Rosslyn Data would have won Share of the Week even if it was only up by a percent. It was actually up by 7% and some hope is re-kindled that maybe one day I can sell at a profit.

Everything pointing downwards

Pointing upwards thanks to writing off a loss.

Here's the ISA and shares portfolio after week 46 of year 6.

			Weekly Change
Cash	£39.08		+£0
Portfolio cost	£68,170.47		-£2,521.19
Portfolio sell value (bid price-commission)	£55,588.26	(-18.5%)	-£396.48
Potential profits	£6,+24.08		-£150.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£3,697.33		-£2,521.19
Yr 6 projected avg monthly profit	£344.41	(9.4%)	-£250.44
Total Dividends	£1,343.15		+£0
Total Profit from sales	£24,123.94		-£2,521.19
Average monthly cash profit	£356.76	(9.8%)	-£36.99
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	57%		-6%

The cost dropped by the £2,521 I had paid for MTFB:Motif Bio and which is almost certainly lost, as they have cancelled their AIM listing following a rejection of the 220:1 share consolidation and massive dilution of existing shareholders which was nothing short of a joke. Directors desperate to keep their salary and stuff the shareholders. Fortunately they didn't get away with it and the whole thing will almost certainly go bust. As a result I've written it off as a loss. This has wrecked my stellar Year 6 performance and brought long term performance down below my 10% target, but 9.4% for the year and 9.8% overall isn't bad, and it's a relief not to have to talk about the MTFB fiasco any more.

Aside from the write-off, JLP:Jubilee Metals dropped £150 to dent paper profits, and the rest of the portfolio also slipped by another £250 on top of that. It could have been much worse as we'll see in a minute with the SIPP.

Big drop in cost from the write-off, and value just down a small amount.

Big tick up as the write-off took away £2,500 worth of loss to narrow the deficit.

The SIPP looks like this after week 290 overall and week 30 of year 6.

			Weekly Change
Cash	£207.54		+£0.35
Portfolio cost	£73,458.48		+£282.97
Portfolio sell value (bid price - commission)	£56,346.81	(-23.3%)	-£1,487.07
Potential profits	£745.52		-£844.78
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,774.62		+£283.32
Yr 6 projected avg monthly profit	£1,232.37	(33.8%)	-£0.16
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,234.06		+£283.32
Average monthly cash profit	£380.10	(10.4%)	+£2.93
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+0%

I was depressed with everything dropping so flogged another 500 CAML;Central Asia Metals shares for 241.77p making £283.32 (30.6%) profit. I feel a bit bad that I've now sold so many, but they are drifting and there's no dividend for ages, whereas OPTI:Optibiotix is ludicrously under-valued so I had to get some more. I bought another 2,547 at 46.745p costing £1,199.55. My holding is now 163,299 giving me 13,299 I'm willing to sell and still keep 150,000 long term. My average price in the SIPP reduced to 60.78p compared to my ISA price of 60.4p. My holding is still down by £22,971 after 6 years, which is beyond frustrating, but my conviction these are going to be life changing is even stronger now, despite these losses.

Nearly everything in this portfolio got hammered, so value dropped by £1,487 and £844 of that was the huge drop in CAML:Cental Asia Metals, compounded by selling some.

Closer to the injection line than the cost line now

Really, really bad performance over the last 6 months. Possibly the worst ever for the SIPP.

The trading account looks like this after week 256 overall and week 48 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,444.85	(-39.1%)	-£54.19
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£59.92	(30.3%)	-£1.27
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£16.89	(8.5%)	-£0.07
(Sold stocks profit + Dividends - Fees / Months)

Most of last week's gains were lost as everything dropped. Still happy that my long term performance is much better than a building society would have been - if I can sort out the fact that the portfolio itself is down by 39% which would wipe out the whole lot if I sold up now.

No sign of recovery, which is relying on good news from DDDD:4D Pharma because the rest is going nowhere fast.

Pretty bad.

So, OPTI:Optibiotix published results which most companies would have been proud of in a Covid year, but the results was absolutely no change in share price from the previous week. In fact, to add insult to injury SBTX:SkinBioTherapeutics climbed much more on the day OPTI released results than OPTI did. I'm just going to pout and sulk for a while and see what next week brings...

Week 305 Review - Yet another bad week but 4D Pharma starts to recover

I guess this is renowned as a bad time of year for share price value, but it's depressing when every time you claw some back, the following week it vanishes again. The deficit between cost and value widened by £3,342 this week to £31,206 and the portfolio value fell to £115,540. The crumb of comfort was that I cashed in a bit more profit.

The worst performer was JLP:Jubilee Metals which fell 30% of my purchase price, but at 327% up it's still my best performing share.

CAML:Central Asia Metals also had a bad week dropping 9%, and the few I sold this week were at an even lower price than that. They are still 42% up, but I've decided to reduce my holding a little as although it's a great company, the recent tailings dam leak shows that mining stocks are always risky and it's best to diversify. They still make up 2.5% of my portfolio, down from about 8% before I started selling. I may stop selling them now.

CMCL:Caledonia Mining dropped 6% in a bad week for all my mining stocks.

Share of the Week was the only significant riser. DDDD:4D Pharma climbed 10% but are still 17% down. I'm hoping this is the start of the recovery though.

I think for next week I can adjust this chart to start at £75K. The flat green line is deceptive due to the increases in both injection and cost.

This is a true reflection of the abject misery I'm feeling.

Here's the ISA and shares portfolio after week 45 of year 6.

			Weekly Change
Cash	£39.08		-£3.75
Portfolio cost	£70,691.67		+£0
Portfolio sell value (bid price-commission)	£55,984.74	(-20.8%)	-£1,720.61
Potential profits	£7,074.08		-£650.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£6,218.52		+£0
Yr 6 projected avg monthly profit	£594.85	(16.3%)	-£13.89
Total Dividends	£1,343.15		+£0
Total Profit from sales	£26,645.13		+£0
Average monthly cash profit	£393.75	(10.8%)	-£1.35
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	63%		+0%

Potential profits fell by £650 thanks to the drop in JLP:Jubilee Metals, but the rest of the portfolio dropped by an additional £1,000 thanks to OPTI:Optibiotix falling yet again. Long term performance is still above target.

Back to being closer to injection than cost.

At least this one is still just above the low of 3 weeks ago.

The SIPP looks like this after week 289 overall and week 29 of year 6.

			Weekly Change
Cash	£207.19		-£101.18
Portfolio cost	£73,175.51		+£379.63
Portfolio sell value (bid price - commission)	£57,550.91	(-21.4%)	-£1,691.57
Potential profits	£1,590.30		-£684.03
Yr 6 Dividends	£874.51		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£7,491.30		+£295.11
Yr 6 projected avg monthly profit	£1,232.53	(33.8%)	-£0.93
Total Dividends	£2,941.59		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£22,950.74		+£295.11
Average monthly cash profit	£377.17	(10.3%)	+£2.88
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	58%		+1%

Potential profits dropped by £684 as only CAML:Central Asia Metals and FXPO:Ferrexpo are in profit now. Fortunately most of my new magic formula shares are only down a few percent, so I'm hoping they will be in profit once spread and commission have cleared. Overall value fell further, mainly thanks to the drop in OPTI:Optibiotix.

The £295 (39.7%) profit was from selling another 400 shares in CAML:Central Asia Metals for 259.33p. I used the proceeds to buy 2,242 share in OPTI:Optibiotix costing £1,112.89. That takes me above 160,000 shares, so I think I really ought to stop now.

Long term performance remains above target, although will fall below target once the next pension transfer injection comes through. The absolutely great news is that my bond fund has increased enough to take me over the minimum £2,200 required to do a transfer this month. I just need to wait a few days for the payment to make it into the account, and then the 10 days it takes to transfer. If DDDD:4D Pharma stays around 100p I'll buy more of that, else magic formula shares. SBTX:SkinBioTherapeutics is still way to expensive to buy.

Even this is getting to the point where it is almost as close to the orange line as the red.

Total disaster - the worse it's been for 12 months.

The trading account looks like this after week 255 overall and week 47 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,499.04	(-36.9%)	+£69.73
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£62.52	(31.6%)	-£1.39
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.03	(8.6%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

A good week thanks to DDDD:4D Pharma climbing 10%. It would have been better if the others hadn't dropped in value. Almost at the end of year 5 and no prospect of selling anything else this year. It will still be a record performance. 

A rare tick upwards!

My only hope is news from DDDD:4D Pharma as everything else is stuck in a hole.

Late writing my blog again this week, so nothing more to pontificate about.